STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference being held in New York, NY from September 9-11, 2024.
Details of the event are as follows:
Fireside Chat Date and Time: Monday, September 9, 2024, at 12:30 p.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company’s website: https://ir.collegiumpharma.com A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:
Christopher James, M.D.
Vice President, Investor Relations
[email protected]
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
[email protected] 
- ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orthofix Medical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OFIX - September 14, 2024
- ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Arbor Realty Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ABR - September 14, 2024
- ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARDX - September 14, 2024
